Lauren E Thurgate1, Daniel A Lemberg1,2, Andrew S Day1,3, Steven T Leach1. 1. School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia. 2. Department of Gastroenterology, Sydney Children's Hospital Randwick, Sydney, New South Wales, Australia. 3. Department of Paediatrics, University of Otago, Christchurch, New Zealand.
Abstract
BACKGROUND: The inflammatory bowel diseases cover a diverse range of conditions generally grouped into Crohn's disease (CD) or ulcerative colitis (UC) based on clinical, laboratory, radiological, endoscopic, and histological criteria. However, inflammatory bowel disease unclassified (IBDU) is used when there are clinical and endoscopic signs of chronic colitis without specific features of UC or CD but features of both. Conjecture exists regarding IBDU, especially in children, as to whether it represents a unique childhood phenotype or whether it reflects the difficulties in assigning an IBD subtype at an early age. SUMMARY: This review examines the current understanding of pediatric IBDU and assesses the evidence supporting IBDU as a distinctive disease entity on the spectrum of inflammatory bowel disease. KEY MESSAGES: Pediatric-onset IBDU is more common than adult-onset IBDU. Therefore, an understanding of IBDU in this age group assumes more importance. However, there remains a paucity of information and a lack of exclusive longitudinal studies on pediatric IBDU. Subsequently there is significant disparity in the reported prevalence, clinical course, reclassification trends, and treatment responses around pediatric IBDU. Therefore, it remains challenging to chart the natural history of pediatric IBDU and consequently form an accurate understanding of where pediatric IBDU sits on the spectrum of disease.
BACKGROUND: The inflammatory bowel diseases cover a diverse range of conditions generally grouped into Crohn's disease (CD) or ulcerative colitis (UC) based on clinical, laboratory, radiological, endoscopic, and histological criteria. However, inflammatory bowel disease unclassified (IBDU) is used when there are clinical and endoscopic signs of chronic colitis without specific features of UC or CD but features of both. Conjecture exists regarding IBDU, especially in children, as to whether it represents a unique childhood phenotype or whether it reflects the difficulties in assigning an IBD subtype at an early age. SUMMARY: This review examines the current understanding of pediatric IBDU and assesses the evidence supporting IBDU as a distinctive disease entity on the spectrum of inflammatory bowel disease. KEY MESSAGES: Pediatric-onset IBDU is more common than adult-onset IBDU. Therefore, an understanding of IBDU in this age group assumes more importance. However, there remains a paucity of information and a lack of exclusive longitudinal studies on pediatric IBDU. Subsequently there is significant disparity in the reported prevalence, clinical course, reclassification trends, and treatment responses around pediatric IBDU. Therefore, it remains challenging to chart the natural history of pediatric IBDU and consequently form an accurate understanding of where pediatric IBDU sits on the spectrum of disease.
Authors: Ryan S Carvalho; Vivian Abadom; Harrison P Dilworth; Richard Thompson; Maria Oliva-Hemker; Carmen Cuffari Journal: Inflamm Bowel Dis Date: 2006-04 Impact factor: 5.325
Authors: Katalin E Müller; Péter L Lakatos; András Arató; Judit B Kovács; Ágnes Várkonyi; Dániel Szűcs; Erzsébet Szakos; Enikő Sólyom; Márta Kovács; Marianne Polgár; Éva Nemes; Ildikó Guthy; István Tokodi; Gergely Tóth; Ágnes Horváth; András Tárnok; Noémi Csoszánszki; Márta Balogh; Noémi Vass; Piroska Bódi; Antal Dezsőfi; László Gárdos; Eva Micskey; Mária Papp; Áron Cseh; Dolóresz Szabó; Péter Vörös; Gabor Veres Journal: J Pediatr Gastroenterol Nutr Date: 2013-11 Impact factor: 2.839
Authors: Melvin B Heyman; Barbara S Kirschner; Benjamin D Gold; George Ferry; Robert Baldassano; Stanley A Cohen; Harland S Winter; Patricia Fain; Chris King; Terry Smith; Hashem B El-Serag Journal: J Pediatr Date: 2005-01 Impact factor: 4.406
Authors: Elizabeth A Newby; Nick M Croft; Michael Green; Kamal Hassan; Robert B Heuschkel; Huw Jenkins; David H Casson Journal: J Pediatr Gastroenterol Nutr Date: 2008-05 Impact factor: 2.839
Authors: Ranjit Pelia; Suresh Venkateswaran; Jason D Matthews; Yael Haberman; David J Cutler; Jeffrey S Hyams; Lee A Denson; Subra Kugathasan Journal: BMC Med Genomics Date: 2021-07-29 Impact factor: 3.063